Benjamin T. Kile
Technik-/Wissenschafts-/F&E-Leiter bei MuriGen Pty Ltd.
Profil
Benjamin T.
Kile is currently the Chief Scientific Officer at MuriGen Pty Ltd.
He previously worked at Baylor College of Medicine as a Principal.
Aktive Positionen von Benjamin T. Kile
| Unternehmen | Position | Beginn |
|---|---|---|
MuriGen Pty Ltd.
 MuriGen Pty Ltd. Pharmaceuticals: MajorHealth Technology MuriGen Pty Ltd. discovers, develops and commercializes drugs. It develops drugs for cancer, arthritis, thrombocytopenia, inflammatory diseases, epilepsy and thalassemia. The company was founded by Douglas James Hilton on September 28, 1999 and is headquartered in Melbourne, Australia. | Technik-/Wissenschafts-/F&E-Leiter | 23.04.2010 |
Ehemalige bekannte Positionen von Benjamin T. Kile
| Unternehmen | Position | Ende |
|---|---|---|
| Baylor College of Medicine | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
MuriGen Pty Ltd.
MuriGen Pty Ltd. Pharmaceuticals: MajorHealth Technology MuriGen Pty Ltd. discovers, develops and commercializes drugs. It develops drugs for cancer, arthritis, thrombocytopenia, inflammatory diseases, epilepsy and thalassemia. The company was founded by Douglas James Hilton on September 28, 1999 and is headquartered in Melbourne, Australia. | Health Technology |
